Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2557 of 5804
-
New pill may boost botox for stubborn neck spasms
Symptom relief Recruiting nowThe most common form of idiopathic dystonia is adult-onset cervical dystonia (CD), a focal form of dystonia affecting the muscles of the neck. CD is often associated with pain and limited range of motion, and frequently leads to reduced quality of life and disability. Effective l…
Phase: PHASE2 • Sponsor: Virginia Commonwealth University • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
New drug HRS-6208 tested in advanced cancer patients
Disease control Recruiting nowThis is an open, multicenter Phase I study to evaluate the safety and tolerability of HRS-6208 in patients with advanced solid tumors.
Phase: PHASE1 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Blood test may speed up deadly fungal infection diagnosis
Diagnosis CompletedInvasive fungal infections (IFI) are a major concern for immunocompromised or vulnerable patients. Associated mortality is significant and depends on the timeliness of diagnostic and therapeutic management. Consequently, biomarkers play a key role in therapeutic strategies compar…
Sponsor: Central Hospital, Nancy, France • Aim: Diagnosis
Last updated Jun 27, 2026 08:03 UTC
-
Crossword puzzles tested as brain booster for memory loss
Symptom relief Recruiting nowEffective, clinically meaningful treatments are lacking for patients with mild cognitive impairment (MCI), which is associated with increased risk of transition to dementia. Cognitive training represents an important therapeutic strategy. In a previous study, crossword puzzles we…
Phase: PHASE2 • Sponsor: Columbia University • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Happiness therapy: new study aims to ease anxiety in transplant survivors
Symptom relief Recruiting nowThis randomized clinical trial is evaluating the impact of a positive psychology intervention (PATH) on anxiety symptoms, depression symptoms, and quality of life in survivors of hematopoietic stem cell transplant (HSCT) compared to usual care.
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
New cancer drug SKB571 enters first human tests
Disease control Recruiting nowThis is a first-in-human (FIH), phase 1, multicenter, open-label study of SKB571 to evaluate the safety, tolerability, PK, immunogenicity, and antitumor activity in adult subjects with advanced or metastatic solid tumor .
Phase: PHASE1 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
MS drug ocrelizumab gets a Needle-Free makeover: new shot form tested
Disease control Recruiting nowThe main purpose of this study is to evaluate the safety and tolerability of the ocrelizumab subcutaneous (SC) test formulation in participants with multiple sclerosis (MS). The study consists of two treatment phases: a dose-escalation and dose-continuation phase. Participants wi…
Phase: PHASE1 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New drug BM230 enters first human trial for Hard-to-Treat cancers
Disease control Recruiting nowThis study is a Phase I, multicenter, non-randomized, open-label, first-in-human study of BM230 conducted globally. The study will include two parts: a dose escalation part (Phase Ia) followed by a dose expansion part (Phase Ib). Phase Ia part will estimate the MTD/RED(s) in dose…
Phase: PHASE1 • Sponsor: Suzhou Biomissile Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New cancer drug OP-3136 enters first human tests
Disease control Recruiting nowThis is a first-in-human, open-label, multicenter phase 1 study to evaluate safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary efficacy of OP-3136, a lysine acetyltransferases 6A and 6B (KAT6A/B) inhibitor, as monotherapy and in combination with o…
Phase: PHASE1 • Sponsor: Olema Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New study: can a Two-Week monitor improve blood sugar control for new insulin users?
Disease control Recruiting nowThe proposed study will be a randomized, prospective, non-blinded study of 120 participants with type 1 or type 2 diabetes that are new-to-insulin on hospital discharge. On hospital discharge, participants will be assigned to either the intervention of wearing a continuous glucos…
Phase: NA • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Spinal morphine may boost recovery after keyhole surgery
Symptom relief Recruiting nowThe goal of this clinical trial is to learn the clinical and cost effectiveness of intrathecal morphine (ITM) in addition to usual care as a postoperative pain relief strategy following major laparoscopic abdominal surgery compared with current usual care. The main questions it a…
Phase: PHASE4 • Sponsor: First Affiliated Hospital, Sun Yat-Sen University • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Brain zaps could ease nerve pain in spinal injury patients
Symptom relief Recruiting nowThe aim of our study is to investigate the effect of different protocols of high-frequency Repetitive Transcranial Magnetic Stimulation (rTMS) therapy added to the rehabilitation program on neuropathic pain,depression, quality of life and quality of sleep compared to each other a…
Phase: NA • Sponsor: Afyonkarahisar Health Sciences University • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
Could whole blood save more trauma patients? new canadian trial aims to find out
Disease control Recruiting nowTraumatic injuries affect people of all ages, races, and socioeconomic backgrounds. The Global Burden of Disease study showed that globally in 2019, there were more than 4.4 million deaths due to injury. Furthermore, unintentional injuries are the leading cause of death for peopl…
Phase: NA • Sponsor: Unity Health Toronto • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Teens take the lead: mindfulness program aims to boost youth mental health
Symptom relief Recruiting nowThe current study tests the feasibility and effectiveness of a youth intervention designed to provide meaningful leadership opportunities through the acquisition of leadership skills as well as mindfulness practice, LEAP: Leadership, Engagement, and youth Action Program with Mind…
Phase: NA • Sponsor: Boston University Charles River Campus • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
Morning light may ease OCD symptoms in night owls
Symptom relief Recruiting nowThe goal of this clinical trial is to test whether light therapy is effective for reducing symptoms in young adults with OCD and late bedtimes (1am or later). The main question\[s\] it aims to answer are: Does light therapy reduce OCD symptoms? Does light therapy advance the cir…
Phase: EARLY_PHASE1 • Sponsor: Washington University School of Medicine • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
New online program aims to help stroke patients get back to living
Symptom relief Recruiting nowThe overall goal of this proposed study is to evaluate the efficacy of a small-group, stroke-specific, self-management program delivered via telehealth to improve self-efficacy, activity performance, and quality of life in individuals with sub-acute stroke.
Phase: NA • Sponsor: University of Missouri-Columbia • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
New drug targets brain inflammation in Alzheimer's
Symptom relief Recruiting nowAn open-label, exploratory, phase II, proof-of concept, clinical study to assess the safety and tolerability of EI-1071 and the effects of EI-1071 on neuroinflammation in patients with mild, moderate, or severe Alzheimer's disease
Phase: PHASE2 • Sponsor: Elixiron Immunotherapeutics Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
No-Opioid anesthesia beats standard for gallbladder surgery recovery
Symptom relief CompletedThis study was a single-center, prospective, randomized clinical trial designed to compare the effects of opioid-free anesthesia (OFA) with standard opioid-based anesthesia during elective laparoscopic cholecystectomy. The aim was to evaluate the impact of these two anesthetic ap…
Phase: NA • Sponsor: Dr. Lutfi Kirdar Kartal Training and Research Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
New study tests whether a navigator can close gaps in breast cancer care
Knowledge-focused Recruiting nowThis clinical trial evaluates a patient navigation program for addressing disparities in breast cancer care. The navigation program is designed to help improve patient knowledge about clinical and supportive care services, navigate to existing services, help manage barriers to ca…
Phase: NA • Sponsor: Roswell Park Cancer Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Could a smartphone app help people on mental health waiting lists feel more prepared?
Symptom relief Recruiting nowCommunity mental health centers (CMHCs) face significant challenges in meeting the needs of individuals with mental health issues. For example, due to high demand, there are long waiting lists and low engagement rates. Innovative interventions are urgently needed to address these…
Phase: NA • Sponsor: St. Olavs Hospital • Aim: Symptom relief
Last updated Jul 23, 2026 00:00 UTC